Cargando…
Psychedelic drugs—a new era in psychiatry?
This article covers the renaissance of classical psychedelic drugs such as psilocybin and LSD plus 3,4-methylene dioxymethamphetamine (MDMA—ecstasy) in psychiatric research. These drugs were used quite extensively before they became prohibited. This ban had little impact on recreational use, but eff...
Autor principal: | Nutt, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787540/ https://www.ncbi.nlm.nih.gov/pubmed/31636488 http://dx.doi.org/10.31887/DCNS.2019.21.2/dnutt |
Ejemplares similares
-
Psychedelic Psychiatry
por: Nutt, D.
Publicado: (2022) -
Commentary: Psychedelic Psychiatry's Brave New World
por: Nobile, Bénédicte, et al.
Publicado: (2020) -
Psychedelics: A new era of treatment?
por: Torres, S.
Publicado: (2021) -
PROPOSAL FOR SYMPOSIUM –ANCIPS, 2022 The New Era Of Psychedelic (Hallucinogen) Associated Treatments In Psychiatry-Will It Be A Game Changer?
por: Jabbar, Jassar Abdul, et al.
Publicado: (2022) -
Psychedelic science in post-COVID-19 psychiatry
por: Kelly, J. R., et al.
Publicado: (2020)